| scholarly article | Q13442814 |
| P2093 | author name string | Songhai Li | |
| Xiaopeng Guo | |||
| Qiutang Zeng | |||
| Yuhua Liao | |||
| Wenping Zhou | |||
| Yumiao Wei | |||
| Weijuan Li | |||
| Yaoqi Chen | |||
| P2860 | cites work | Superoxide production and expression of nox family proteins in human atherosclerosis | Q43933078 |
| Autoantibodies against AT1-receptor and alpha1-adrenergic receptor in patients with hypertension | Q44162378 | ||
| C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle | Q44382946 | ||
| AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase | Q44385661 | ||
| Angiotensin II receptor blocker valsartan suppresses reactive oxygen species generation in leukocytes, nuclear factor-kappa B, in mononuclear cells of normal subjects: evidence of an antiinflammatory action | Q44582536 | ||
| Global suppression of IL-6-induced acute phase response gene expression after chronic in vivo treatment with the peroxisome proliferator-activated receptor-alpha activator fenofibrate | Q44756924 | ||
| Cardiac remodeling after long-term stimulation by antibodies against the alpha1-adrenergic receptor in rats | Q45216646 | ||
| Broad-spectrum CC-chemokine blockade by gene transfer inhibits macrophage recruitment and atherosclerotic plaque formation in apolipoprotein E-knockout mice | Q45240037 | ||
| Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection | Q45259438 | ||
| Rapamycin modulates the eNOS vs. shear stress relationship | Q46851063 | ||
| Antiinflammatory and antiatherogenic effects of the NF-kappaB inhibitor acetyl-11-keto-beta-boswellic acid in LPS-challenged ApoE-/- mice | Q46886406 | ||
| Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis | Q46897070 | ||
| Oxidative stress and vascular disease: 2005 Duff lecture | Q48561087 | ||
| Gene transfer of a broad spectrum CC-chemokine inhibitor reduces vein graft atherosclerosis in apolipoprotein E-knockout mice. | Q50754865 | ||
| Agonistic autoantibodies to the AT1 receptor in a transgenic rat model of preeclampsia. | Q52940276 | ||
| Endothelial adhesion molecules and leukocyte integrins in preeclamptic patients. | Q53003372 | ||
| Agonistic Angiotensin II Type 1 Receptor Autoantibodies in Postpartum Women With a History of Preeclampsia | Q56981931 | ||
| AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor | Q73815485 | ||
| Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension | Q74126541 | ||
| Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice | Q77231603 | ||
| Endothelial-cell permeability and protein kinase C in pre-eclampsia | Q77292367 | ||
| Cytokines in the pathogenesis of atherosclerosis | Q78321128 | ||
| Unstable coronary-artery plaques | Q79359326 | ||
| Fenofibrate reduces atherogenesis in ApoE*3Leiden mice: evidence for multiple antiatherogenic effects besides lowering plasma cholesterol | Q80012062 | ||
| Angiotensin II type 1 receptor blocker reduces monocyte adhesion to endothelial cells in spontaneously hypertensive rats | Q80642855 | ||
| Target organ protection from a novel angiotensin II receptor (AT1) vaccine ATR12181 in spontaneously hypertensive rats | Q83333351 | ||
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice | Q28364478 | ||
| Inflammation, atherosclerosis, and coronary artery disease | Q29547232 | ||
| Inflammation in atherosclerosis | Q29547428 | ||
| NAD(P)H oxidase: role in cardiovascular biology and disease | Q29616102 | ||
| NF-kappaB: a key role in inflammatory diseases | Q29617726 | ||
| Nuclear factor-{kappa}B activation contributes to vascular endothelial dysfunction via oxidative stress in overweight/obese middle-aged and older humans | Q33606974 | ||
| Oxidative stress as a regulator of gene expression in the vasculature | Q33751805 | ||
| Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor | Q33848380 | ||
| Vascular inflammation and the renin-angiotensin system | Q33960784 | ||
| Peroxisome proliferator-activated receptors in inflammation control | Q34262753 | ||
| Current concepts of the pathogenesis of the acute coronary syndromes | Q34310339 | ||
| Renin-angiotensin system and atherothrombotic disease: from genes to treatment | Q35136362 | ||
| Regulation of superoxide anion production by NADPH oxidase in monocytes/macrophages: contributions to atherosclerosis | Q35549957 | ||
| Oxidative stress and preeclampsia: rationale for antioxidant clinical trials | Q35869763 | ||
| Chemokines in the pathogenesis of vascular disease | Q35932790 | ||
| Nuclear factor kappaB signaling in atherogenesis. | Q36054434 | ||
| Agonistic AT(1) receptor autoantibody increases in serum of patients with refractory hypertension and improves Ca(2+) mobilization in cultured rat vascular smooth muscle cells | Q36295460 | ||
| Boswellic acids in chronic inflammatory diseases | Q36616085 | ||
| Cyclooxygenase-2 inhibition increases lipopolysaccharide-induced atherosclerosis in mice | Q37090545 | ||
| NADPH oxidase contributes to coronary endothelial dysfunction in the failing heart | Q37138926 | ||
| Brain nuclear factor-kappa B activation contributes to neurohumoral excitation in angiotensin II-induced hypertension | Q37193534 | ||
| NADPH oxidase-dependent signaling in endothelial cells: role in physiology and pathophysiology | Q37265507 | ||
| Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor alpha in pregnant rats | Q37436219 | ||
| Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1. | Q37447371 | ||
| Silencing T-bet defines a critical role in the differentiation of autoreactive T lymphocytes | Q38334406 | ||
| Reciprocal and coordinate regulation of serum amyloid A versus apolipoprotein A-I and paraoxonase-1 by inflammation in murine hepatocytes | Q40278061 | ||
| Synergistic vascular protective effects of combined low doses of PPARalpha and PPARgamma activators in angiotensin II-induced hypertension in rats | Q41556931 | ||
| C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. | Q42456186 | ||
| Evidence for the involvement of NADPH oxidase in ischemia/reperfusion-induced gastric damage via angiotensin II. | Q43076902 | ||
| Endothelial dysfunction of coronary resistance vessels in apoE-/- mice involves NO but not prostacyclin-dependent mechanisms | Q43823295 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 678-690 | |
| P577 | publication date | 2014-11-22 | |
| P1433 | published in | American Journal of Translational Research | Q4744272 |
| P1476 | title | Agonistic antibody to angiotensin II type 1 receptor accelerates atherosclerosis in ApoE-/- mice | |
| P478 | volume | 6 |
| Q90298825 | Apolipoprotein B-100 peptide 210 antibody inhibits atherosclerosis by regulation of macrophages that phagocytize oxidized lipid |
| Q90599535 | Autoantibodies against AT1 Receptor Contribute to Vascular Aging and Endothelial Cell Senescence |
| Q36270611 | Effect of metabolic control on oxidative stress, subclinical atherosclerosis and peripheral artery disease in diabetic patients |
| Q36556973 | Preparation and Biological Activity of the Monoclonal Antibody against the Second Extracellular Loop of the Angiotensin II Type 1 Receptor |
Search more.